Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Jul 12;8:10558. doi: 10.1038/s41598-018-28970-1

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2018

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Truncation of β-dystroglycan in cortical microvasculature during abstinence from Meth. (A) 3 days of abstinence from Meth. CUS + Meth compared to CUS (*p < 0.01) and Meth (^#p < 0.01) n = 7–8/group. Middle panel shows representative blot of full and truncated forms of β-dystroglycan after 3 days of abstinence from Meth and the bottom panel shows the loading control α-tubulin. (B) COX-2 inhibitor nimesulide treatment during 3 days of abstinence CUS + Meth vs. Meth (^#p < 0.01) n = 6–8/group. Line indicates controls that did not receive nimesulide treatments. Middle panel shows representative blot of full and truncated forms of β-dystroglycan in nimesulide treated groups after 3 days of abstinence from Meth and the bottom panel shows the loading control α-tubulin. (C) 7 days of abstinence from Meth and β-dystroglycan in CUS + Meth vs Meth (^#p < 0.01) n = 6/group. Middle panel shows representative blot of full and truncated forms of β-dystroglycan after 7 days of abstinence from Meth and the bottom panel shows the loading control α-tubulin. (D) COX-2 inhibitor nimesulide treatment during 7 days of abstinence. Line indicates controls that did not receive nimesulide treatments. Middle panel shows representative blot of full and truncated forms of β-dystroglycan after nimesulide during 7 days of abstinence from Meth and the bottom panel shows the loading control α-tubulin. β-dystroglycan and α-tubulin band images presented have been vertically sliced in order to juxtapose lanes that were non-adjacent in the blot. Full-length blots are presented in Supplementary Figures S4A, S4B, S4C and S4D.